Cardiac Tissue Engineering Market Anticipated To Witness Robust Growth, Surpassing 1.63 Billion By 2029

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Current Cardiac Tissue Engineering Market Size and Its Estimated Growth Rate?
The market size for cardiac tissue engineering has seen a fast-paced expansion in the last few years. It is set to surge from $0.67 billion in 2024 to about $0.81 billion in 2025, marking a compound annual growth rate (CAGR) of 19.7%. The increases observed in the historical period can be traced back to a shortage of organ donors, an escalating occurrence of cardiovascular ailments, biomaterial innovations, a rise in regenerative medicine investments, the push for personalized medicine, developments in bioreactor mechanisms, a boost in government support for biomedical studies, and a growing emphasis on minimally invasive treatment methods.

The market size for cardiac tissue engineering is slated for robust growth in the next few years, escalating to $1.64 billion in 2029 with a compound annual growth rate (CAGR) of 19.4%. The expected growth during this forecast period can be associated with increasing requirements for personalized cardiac treatments, intensified emphasis on bioengineered heart tissues, widened scope of regenerative medicine applications, and increased alliances between biotech companies and academic institutions. Other growth factors include a rise in investment in preclinical test platforms and a growing prevalence of chronic heart conditions. Key trends for the coming period comprise the implementation of AI in tissue engineering, advancements in nanotechnology-based scaffolding, the creation of biodegradable hydrogels, advancements in 3D bioprinting accuracy, the employment of bioreactors for tissue maturation, and gene editing aimed at improving cardiac cells.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21129

How Are Emerging Segments Shaping the Cardiac Tissue Engineering Market Landscape?
The cardiac tissue engineering market covered in this report is segmented -

1) By Product: Heart Valves, Vascular Grafts
2) By Material: Stem Cells, Scaffolds
3) By Application: Myocardial Infarction, Heart Valve Repair Or Replacement, Congenital Heart Disease Treatment, Other Applications
4) By End Users: Hospitals And Clinics, Academic And Research Institutes, Other End Users

Subsegments:
1) By Heart Valves: Bioprosthetic Heart Valves, Mechanical Heart Valves, Tissue-Engineered Heart Valves
2) By Vascular Grafts: Synthetic Vascular Grafts, Biologic Vascular Grafts, Tissue-Engineered Vascular Grafts

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21129&type=smp

Which Growth Factors Are Influencing Cardiac Tissue Engineering Market Expansion?
An increase in cardiovascular diseases is anticipated to boost the cardiac tissue engineering market's growth in the future. This interdisciplinary field is centered around the production of biological or bioartificial constructs used for repairing, regenerating, or replacing damaged heart tissue. The surge in cardiovascular diseases is mainly due to unhealthy lifestyle habits such as poor eating habits, lack of physical activity, smoking, and the increasing instances of obesity and diabetes. Biomaterials, cell-based therapies, and bioengineered tissues, used for repairing or regenerating damaged heart muscle and restoring cardiac functionality, are being developed through cardiac tissue engineering in response to cardiovascular diseases. As an example, data from the US-based Centers for Disease Control and Prevention in May 2023 showed that coronary heart disease in adult women aged 18 and over had a slight rise to 3.7% in 2023 from 3.6% in the previous year. Thus, the rise in cardiovascular diseases is acting as a catalyst to drive the cardiac tissue engineering market's expansion.

Who Are the Dominant Players Across Different Cardiac Tissue Engineering Market Segments?
Major companies operating in the cardiac tissue engineering market are Biotronik SE & Co. KG, Terumo Corporation, Artivion Inc., Tissue Regenix Group plc, PromoCell GmbH, Xeltis AG, Carmat S.A., Bioheart Inc., Prellis Biologics Inc., Cytograft Tissue Engineering Inc., Avery Therapeutics Inc., Vascudyne Inc., Auto Tissue Berlin GmbH, CorMatrix Cardiovascular Inc., Humacyte Inc., BioCardia Inc., Osiris Therapeutics Inc., StemCells Inc., ViroMed Co. Ltd., Cardio3 Biosciences

What Trends Are Driving Growth in The Cardiac Tissue Engineering Market?
Leading organisations in the cardiac tissue engineering market are concentrating on developing innovative technologies, such as 3D-engineered muscle tissues, to improve the precision and effectiveness of drug discovery for comprehensive treatments for heart-related diseases. 3D-engineered muscle tissues, essentially used for drug testing and disease modelling, are bioengineered constructs which reproduce the structural and functional characteristics of human muscle. For example, in July 2022, a US-based biotechnology firm, Curi Bio Inc., introduced the Mantarray platform for human-relevant 3D heart and skeletal engineered muscle tissue (EMT) contractility analysis. The platform utilises sophisticated tissue culture methods to create highly functional muscle tissues that mimic the mechanical properties and behaviours of natural muscle, providing a more precise model for testing medicinal drugs. This technology is devised to enhance the progression of therapeutic remedies by enabling researchers to examine muscle contraction, responses to stimuli, and disease modelling at a cellular level.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/cardiac-tissue-engineering-global-market-report

Which Geographic Regions Are Expected to Dominate the Cardiac Tissue Engineering Market in the Coming Years?
North America was the largest region in the cardiac tissue engineering market in 2024. The regions covered in the cardiac tissue engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Cardiac Tissue Engineering Market?
2. What is the CAGR expected in the Cardiac Tissue Engineering Market?
3. What Are the Key Innovations Transforming the Cardiac Tissue Engineering Industry?
4. Which Region Is Leading the Cardiac Tissue Engineering Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.